In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ImClone Systems Inc.

Division of Eli Lilly & Co.
www.imclone.com

Latest From ImClone Systems Inc.

Appointments: New CEO For Silence Therapeutics, Medical Heads Join Merck, Breath Therapeutics, Immusoft

David Solomon’s entrance as Silence Therapeutics’ new CEO leads this week’s new hires. While Ireland-based Malin shakes up its board of directors, other execs join Merck, Apeiron Biologics, Vectura, Roivant, OncoSec, Breath Therapeutics, Immusoft and M3 Biotechnology.

Appointments BioPharmaceutical

Appointments: Ionis, ThromboGenics, Zelluna, Therapix, OncoSec, Orion, Storm Therapeutics and ALK

This week's round-up includes new CEOs at Zelluna, Therapix Biosciences and OncoSec Medical, a new COO at Ionis, two C-Suite appointments at ThromboGenics, and a new oncology head at Orion.

Appointments BioPharmaceutical

Threshold And Molecular Templates Merge To Test The Power Of Two

Although a vehicle for Molecular Templates to take its Engineered Toxin Bodies oncology platform public, the combined company also will seek a pathway to approval for Threshold's evofosfamide for pancreatic cancer in Japan.

Commercial Deals

From Y/Z To Goodbye: Lechleiter's Lilly Legacy

Outgoing Eli Lilly CEO and president John Lechleiter looks back over his biggest strategic decisions while at the helm of the pharma major and pinpoints some of the key navigational markers for the next phase in Lilly's lifespan.

Leadership Strategy
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Brian Batchelder, VP, CFO
    Jerry Kinzel, PhD, Pres. & Managing Dir.
  • Contact Info
  • ImClone Systems Inc.
    Phone: (908) 541-8100
    440 Route 22 East
    Bridgewater, NJ 08807
    USA
UsernamePublicRestriction

Register